Cargando…

Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a high heterogeneous group of tumors with a distinctly aggressive nature and high rates of relapse. So far, the lack of any known targetable proteins has not allowed a specific anti-tumor treatment. Therefore, the identification of novel agents for specific TN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camorani, Simona, Granata, Ilaria, Collina, Francesca, Leonetti, Francesco, Cantile, Monica, Botti, Gerardo, Fedele, Monica, Guarracino, Mario Rosario, Cerchia, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103779/ https://www.ncbi.nlm.nih.gov/pubmed/32222697 http://dx.doi.org/10.1016/j.isci.2020.100979

Ejemplares similares

Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer
por: Camorani, Simona, et al.
Publicado: (2018)

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
por: Camorani, Simona, et al.
Publicado: (2020)

Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
por: Camorani, Simona, et al.
Publicado: (2017)

Aptamers and antibodies: rivals or allies in cancer targeted therapy?
por: Agnello, Lisa, et al.
Publicado: (2021)

TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities
por: Camorani, Simona, et al.
Publicado: (2018)

Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles
por: Ibarra, Luis Exequiel, et al.
Publicado: (2022)

Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof
por: Shigdar, Sarah, et al.
Publicado: (2021)

Aptamer-Based Strategies to Boost Immunotherapy in TNBC
por: Agnello, Lisa, et al.
Publicado: (2023)

Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
por: Agnello, Lisa, et al.
Publicado: (2021)

Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells
por: Camorani, Simona, et al.
Publicado: (2022)

Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells
por: Camorani, Simona, et al.
Publicado: (2015)

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
por: Agnello, Lisa, et al.
Publicado: (2023)

Optimization of Short RNA Aptamers for TNBC Cell Targeting
por: Camorani, Simona, et al.
Publicado: (2022)

Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2015)

Overexpression of Cell Cycle Progression Inhibitor Geminin is Associated with Tumor Stem-Like Phenotype of Triple-Negative Breast Cancer
por: Di Bonito, Maurizio, et al.
Publicado: (2012)

LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of Triple Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2019)

Coupling Aptamers to Short Interfering RNAs as Therapeutics
por: Cerchia, Laura, et al.
Publicado: (2011)

Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
por: Camorani, Simona, et al.
Publicado: (2017)

Novel Human Bispecific Aptamer–Antibody Conjugates for Efficient Cancer Cell Killing
por: Passariello, Margherita, et al.
Publicado: (2019)

Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-κB
por: Camorani, Simona, et al.
Publicado: (2018)

Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients
por: Botti, Gerardo, et al.
Publicado: (2017)

Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells
por: Passariello, Margherita, et al.
Publicado: (2020)

Coexistence of Granular Cell Tumor and Invasive Ductal Breast Cancer in Contralateral Breasts: A Case Report
por: Di Bonito, Maurizio, et al.
Publicado: (2014)

Long Non-Coding RNA HOTAIR in Breast Cancer Therapy
por: Cantile, Monica, et al.
Publicado: (2020)

Borderline Brenner tumor of the ovary: a case report with immunohistochemical and molecular study
por: De Cecio, Rossella, et al.
Publicado: (2014)

Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5
por: D’Esposito, Vittoria, et al.
Publicado: (2016)

Morphological and pathological features of basal-like breast cancer
por: Botti, Gerardo, et al.
Publicado: (2019)

Adenoma of the nipple: A clinicopathological report of 13 cases
por: DI BONITO, MAURIZIO, et al.
Publicado: (2014)

Molecular strategies for detecting chromosomal translocations in soft tissue tumors (Review)
por: CERRONE, MARGHERITA, et al.
Publicado: (2014)

PD-L1 Immunohistochemical Detection in Tumor Cells and Tumor Microenvironment: Main Considerations on the Use of Tissue Micro Arrays
por: Botti, Gerardo, et al.
Publicado: (2016)

Developmental Gene Markers in Tumor Pathogenesis and Progression
por: Cantile, Monica, et al.
Publicado: (2019)

Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer
por: Alexandrova, Elena, et al.
Publicado: (2020)

Pathological and molecular characteristics of inflammatory breast cancer
por: Di Bonito, Maurizio, et al.
Publicado: (2019)

Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis
por: Di Bonito, Maurizio, et al.
Publicado: (2012)

Erratum to: Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis
por: Di Bonito, Maurizio, et al.
Publicado: (2013)

Sex Hormone Receptors in Benign and Malignant Salivary Gland Tumors: Prognostic and Predictive Role
por: Aquino, Gabriella, et al.
Publicado: (2018)

New Prognostic and Predictive Markers in Head and Neck Tumors
por: Cantile, Monica, et al.
Publicado: (2016)

Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Ha-Ras(V12) Oncogene
por: Vitiello, Michela, et al.
Publicado: (2019)

Integration of transcriptomic data in a genome-scale metabolic model to investigate the link between obesity and breast cancer
por: Granata, Ilaria, et al.
Publicado: (2019)

Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers
por: Di Mauro, Concetta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c8v8558mm0lme4j9r8sdtdc6ke